173 related articles for article (PubMed ID: 35101137)
1. Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.
Rosenberger A; Muttray N; Hung RJ; Christiani DC; Caporaso NE; Liu G; Bojesen SE; Le Marchand L; Albanes D; Aldrich MC; Tardon A; Fernández-Tardón G; Rennert G; Field JK; Davies MPA; Liloglou T; Kiemeney LA; Lazarus P; Wendel B; Haugen A; Zienolddiny S; Lam S; Schabath MB; Andrew AS; Duell EJ; Arnold SM; Goodman GE; Chen C; Doherty JA; Taylor F; Cox A; Woll PJ; Risch A; Muley TR; Johansson M; Brennan P; Landi MT; Shete SS; Amos CI; Bickeböller H;
Eur J Med Res; 2022 Jan; 27(1):14. PubMed ID: 35101137
[TBL] [Abstract][Full Text] [Related]
2. High-order gene interactions between the genetic polymorphisms in Wnt and AhR pathway in modulating lung cancer susceptibility.
Bahl C; Singh N; Behera D; Sharma S
Per Med; 2017 Nov; 14(6):487-502. PubMed ID: 29749862
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the AHR gene proximal promoter GGGGC-repeat polymorphism in lung, breast, and colon cancer.
Spink BC; Bloom MS; Wu S; Sell S; Schneider E; Ding X; Spink DC
Toxicol Appl Pharmacol; 2015 Jan; 282(1):30-41. PubMed ID: 25447411
[TBL] [Abstract][Full Text] [Related]
5. Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
Lee CC; Yang WH; Li CH; Cheng YW; Tsai CH; Kang JJ
Cancer Lett; 2016 Jul; 376(2):211-7. PubMed ID: 27060206
[TBL] [Abstract][Full Text] [Related]
6. Interactive potential of genetic polymorphism in Xenobiotic metabolising and DNA repair genes for predicting lung cancer predisposition and overall survival in North Indians.
Bhardwaj A; Bahl C; Sharma S; Singh N; Behera D
Mutat Res Genet Toxicol Environ Mutagen; 2018 Feb; 826():15-24. PubMed ID: 29412865
[TBL] [Abstract][Full Text] [Related]
7. A UVB-responsive common variant at chromosome band 7p21.1 confers tanning response and melanoma risk via regulation of the aryl hydrocarbon receptor, AHR.
Xu M; Mehl L; Zhang T; Thakur R; Sowards H; Myers T; Jessop L; Chesi A; Johnson ME; Wells AD; Michael HT; Bunda P; Jones K; Higson H; Hennessey RC; Jermusyk A; Kovacs MA; Landi MT; Iles MM; Goldstein AM; ; Choi J; Chanock SJ; Grant SFA; Chari R; Merlino G; Law MH; Brown KM
Am J Hum Genet; 2021 Sep; 108(9):1611-1630. PubMed ID: 34343493
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants in the Wingless Antagonist Genes (
Bahl C; Singh N; Behera D; Sharma S
Cancer Biother Radiopharm; 2018 Dec; 33(10):466-477. PubMed ID: 30346805
[No Abstract] [Full Text] [Related]
9. Adaptive changes in global gene expression profile of lung carcinoma A549 cells acutely exposed to distinct types of AhR ligands.
Procházková J; Strapáčová S; Svržková L; Andrysík Z; Hýžďalová M; Hrubá E; Pěnčíková K; Líbalová H; Topinka J; Kléma J; Espinosa JM; Vondráček J; Machala M
Toxicol Lett; 2018 Aug; 292():162-174. PubMed ID: 29704546
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Profiling Identifies Cell Proliferation and Inflammation as the Predominant Pathways Regulated by Aryl Hydrocarbon Receptor in Primary Human Fetal Lung Cells Exposed to Hyperoxia.
Shivanna B; Maity S; Zhang S; Patel A; Jiang W; Wang L; Welty SE; Belmont J; Coarfa C; Moorthy B
Toxicol Sci; 2016 Jul; 152(1):155-68. PubMed ID: 27103661
[TBL] [Abstract][Full Text] [Related]
11. A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohn's Disease.
Prager M; Büttner J; Grunert P; Ellinghaus D; Büning C
Inflamm Bowel Dis; 2016 Oct; 22(10):2356-68. PubMed ID: 27598741
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide mapping and analysis of aryl hydrocarbon receptor (AHR)- and aryl hydrocarbon receptor repressor (AHRR)-binding sites in human breast cancer cells.
Yang SY; Ahmed S; Satheesh SV; Matthews J
Arch Toxicol; 2018 Jan; 92(1):225-240. PubMed ID: 28681081
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
[TBL] [Abstract][Full Text] [Related]
14. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5
Hung RJ; Spitz MR; Houlston RS; Schwartz AG; Field JK; Ying J; Li Y; Han Y; Ji X; Chen W; Wu X; Gorlov IP; Na J; de Andrade M; Liu G; Brhane Y; Diao N; Wenzlaff A; Davies MPA; Liloglou T; Timofeeva M; Muley T; Rennert H; Saliba W; Ryan BM; Bowman E; Barros-Dios JM; Pérez-Ríos M; Morgenstern H; Zienolddiny S; Skaug V; Ugolini D; Bonassi S; van der Heijden EHFM; Tardon A; Bojesen SE; Landi MT; Johansson M; Bickeböller H; Arnold S; Le Marchand L; Melander O; Andrew A; Grankvist K; Caporaso N; Teare MD; Schabath MB; Aldrich MC; Kiemeney LA; Wichmann HE; Lazarus P; Mayordomo J; Neri M; Haugen A; Zhang ZF; Ruano-Raviña A; Brenner H; Harris CC; Orlow I; Rennert G; Risch A; Brennan P; Christiani DC; Amos CI; Yang P; Gorlova OY
J Thorac Oncol; 2019 Aug; 14(8):1360-1369. PubMed ID: 31009812
[TBL] [Abstract][Full Text] [Related]
15. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor activation and overexpression upregulated fibroblast growth factor-9 in human lung adenocarcinomas.
Wang CK; Chang H; Chen PH; Chang JT; Kuo YC; Ko JL; Lin P
Int J Cancer; 2009 Aug; 125(4):807-15. PubMed ID: 19358281
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
Gentil M; Hugues P; Desterke C; Telliam G; Sloma I; Souza LEB; Baykal S; Artus J; Griscelli F; Guerci A; Johnson-Ansah H; Foudi A; Bennaceur-Griscelli A; Turhan AG
PLoS One; 2018; 13(8):e0200923. PubMed ID: 30091999
[TBL] [Abstract][Full Text] [Related]
18. Loss of Aryl Hydrocarbon Receptor Promotes Colon Tumorigenesis in
Han H; Davidson LA; Hensel M; Yoon G; Landrock K; Allred C; Jayaraman A; Ivanov I; Safe SH; Chapkin RS
Mol Cancer Res; 2021 May; 19(5):771-783. PubMed ID: 33495399
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling.
Ye M; Zhang Y; Gao H; Xu Y; Jing P; Wu J; Zhang X; Xiong J; Dong C; Yao L; Zhang J; Zhang J
Clin Cancer Res; 2018 Mar; 24(5):1227-1239. PubMed ID: 29229632
[No Abstract] [Full Text] [Related]
20. Aryl Hydrocarbon Receptor Mediates Cell Proliferation Enhanced by Benzo[a]pyrene in Human Lung Cancer 3D Spheroids.
Jimma Y; Jimma K; Yachi M; Hakata S; Habano W; Ozawa S; Terashima J
Cancer Invest; 2019; 37(8):367-375. PubMed ID: 31462083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
